Minitablets
Minitablets: Enhancing Safety and Palatability for Pediatric Medicines
Gus LaBella
Mikart
PAO-09-24-CL-01Aug 30, 2024
Developability
Assessing Developability and Designing Advanceable Formulations from the Start
Nazar Elkarim, Ph.D.
Mikart
PAO-09-24-CL-02Aug 26, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09Feb 26, 2024
CDMO
Maximizing Outsourcing Benefits for Virtual Pharma Companies
William Kazimier
Tedor Pharma Services
PAO-09-23-CL-08Jan 11, 2024
Formulation
Addressing Swallowing and Palatability Issues with Patient-Friendly Dosage Forms
Gus LaBella
Mikart
PAO-09-23-CL-04Oct 03, 2023
OSD and Liquid
Reshoring Manufacturing and Targeted, Specialty Medicines
Mikart
PAO-05-22-R250-05May 17, 2022
Advanced Excipients
How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs
Daniel Joseph Price, Ph.D.
MilliporeSigma
PAO-04-022-CL-07Apr 27, 2022
Streamlining OSD Operations from Tableting through Serialization
Richard Walkup
Avara Pharmaceutical Services
PA789Oct 21, 2021
Tablet Coating
An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility
Thomas Kipping, Ph.D.
MilliporeSigma
PAO-09-21-CL-06Sep 14, 2021
Solving the Patient-Centric Formulation Riddle
Beau Garrett
Tapemark
PA806Sep 09, 2021
Orally Disintegrating Tablets
A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs
Bill McCarthy; Geetha Thanga Mariappan, Ph.D.
SPI Pharma
PAO-07-21-CL-03Jul 13, 2021
Launch
SPI Pharma Launches UltraBurst™, the First In Class Preformulated Platform for Flash Orally Dispersible Tablets
SPI Pharma
PR-M07-21-03Jul 12, 2021
OSD Technology
Patient-Centric Innovations in OSD
BDD Pharma
PAO-04-22-R221-11Apr 09, 2021
Specialized OSD Services
Avara Pharmaceutical Services: Specialization with a Client-Centric Approach
Deborah A. Graham
Avara Pharmaceutical Services
PAP-Q4-20-CL-003Dec 09, 2020
The Future of Healthcare
How Does Avara Pharmaceutical Services Envision the Future of the Pharma/Biopharma Industry?
Avara Pharmaceutical Services
PAP-Q4-20-RT2-011Dec 09, 2020
Nice Insight Overview
The Benefits of Expanding OSD Capacity
Nigel Walker
Nice Insight
PAP-Q3-20-NI-001Sep 29, 2020
The Future of Healthcare
How Is Avara Pharmaceutical Services Evolving its Business Model to Meet the Future of Healthcare?
Avara Pharmaceutical Services
PAP-Q3-20-RT2-003Sep 29, 2020
Over-the-Counter Conversions
Avara Pharmaceutical Services: Achieving Successful OSD Rx-to-OTC Conversions
Patrick Hatem
Avara Pharmaceutical Services
PAP-Q3-20-CL-007Sep 29, 2020
The Future of Healthcare
How is Avara Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
Avara Pharmaceutical Services
PAP-Q2-20-RT2-010Jul 01, 2020
M&A
Piramal Pharma Solutions Announces Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.
Piramal Pharma Solutions
PR-M06-20-NI-033Jun 25, 2020